EP2930184
DKK-1 mótefni
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
6.4.2010EP published:
27.3.2019EP application number:
15159780.4
EP translation filed:
10.4.2019Grant published:
15.5.2019EPO information:
European Patent Register
Max expiry date:
5.4.2030Expiry date:
5.4.2026Next due date:
30.4.2026
Title:
DKK-1 ANTIBODIES
Timeline
Today
6.4.2010EP application
27.3.2019EP Publication
10.4.2019Translation submitted
15.5.2019Registration published
5.4.2026Expires
Owner
Name:
Eli Lilly and CompanyAddress:
Lilly Corporate Center, 46285, Indianapolis, IN, US
Inventor
Name:
Chedid, MarcioAddress:
Indianapolis, IN, US
Name:
Darling, Ryan JamesAddress:
Indianapolis, IN, US
Name:
Galvin, Rachelle JeanetteAddress:
Indianapolis, IN, US
Name:
Swanson, Barbara AnneAddress:
Indianapolis, IN, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
168411 PDate:
10.4.2009Country:
US
Classification
Categories:
C07K 16/18, A61K 39/00
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 23.5.2019
Expires: 5.4.2020
Payer: Árnason Faktor
Number: 11
Paid: 13.3.2020
Expires: 5.4.2021
Payer: Örn Þór slf.
Number: 12
Paid: 23.3.2021
Expires: 5.4.2022
Payer: Patice ehf.
Number: 13
Paid: 22.3.2022
Expires: 5.4.2023
Payer: Patice ehf.
Number: 14
Paid: 25.3.2023
Expires: 5.4.2024
Payer: Árnason Faktor ehf.
Number: 15
Paid: 20.3.2024
Expires: 5.4.2025
Payer: Árnason Faktor ehf.
Number: 16
Paid: 2.4.2025
Expires: 5.4.2026
Payer: Árnason Faktor ehf.